CONTINGENT VALUE RIGHTS AGREEMENT BETWEEN GEMINI THERAPEUTICS, INC. and CONTINENTAL STOCK TRANSFER AND TRUST COMPANY Dated as of December 29, 2022Contingent Value Rights Agreement • December 29th, 2022 • Disc Medicine, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledDecember 29th, 2022 Company Industry JurisdictionTHIS CONTINGENT VALUE RIGHTS AGREEMENT (this “Agreement”), dated as of December 29, 2022 is entered into by and among Gemini Therapeutics, Inc. a Delaware corporation (“Gem”), and Continental Stock Transfer and Trust Company, as initial Rights Agent (as defined herein).
FORM OF CONTINGENT VALUE RIGHTS AGREEMENT BETWEEN Gemini Therapeutics, Inc. and Dated as of [•]Contingent Value Rights Agreement • August 10th, 2022 • Gemini Therapeutics, Inc. /DE • Pharmaceutical preparations • Delaware
Contract Type FiledAugust 10th, 2022 Company Industry JurisdictionTHIS CONTINGENT VALUE RIGHTS AGREEMENT (this “Agreement”), dated as of [•], is entered into by and among Gemini Therapeutics, Inc. a Delaware corporation (“Gem”), [[___], as Holder’s Representative,] and [•], as initial Rights Agent (as defined herein).